{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 448140429
| IUPAC_name = 5-&#x200b;chloro-&#x200b;2,2-&#x200b;dimethyl-&#x200b;''N''-&#x200b;(8-&#x200b;methyl-&#x200b;8-&#x200b;azabicyclo&#x200b;[3.2.1]oct-&#x200b;3-&#x200b;yl)-&#x200b;2,3-&#x200b;dihydro-&#x200b;1-&#x200b;benzofuran-&#x200b;7-&#x200b;carboxamide
| image = Zatosetron.svg
| width = 230

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 123482-22-4
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 60763
|  ChemSpiderID = 16736584
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 901MC95XSB

<!--Chemical data-->
| C=19 | H=25 | Cl=1 | N=2 | O=2 
| molecular_weight = 348.867 g/mol
|  smiles = CC1(Cc2cc(cc(c2O1)C(=O)N[C@H]3C[C@H]4CC[C@@H](C3)N4C)Cl)C
|  StdInChI = 1S/C19H25ClN2O2/c1-19(2)10-11-6-12(20)7-16(17(11)24-19)18(23)21-13-8-14-4-5-15(9-13)22(14)3/h6-7,13-15H,4-5,8-10H2,1-3H3,(H,21,23)/t13-,14+,15-
|  StdInChIKey = SPKBYQZELVEOLL-QDMKHBRRSA-N
}}

'''Zatosetron''' ('''LY-277,359''') is a drug which acts as an [[Antagonist (pharmacology)|antagonist]] at the [[5-HT3 receptor|5HT<sub>3</sub>]] [[Receptor (biochemistry)|receptor]]<ref>{{cite journal | last1 = Cohen | first1 = ML | last2 = Bloomquist | first2 = W | last3 = Gidda | first3 = JS | last4 = Lacefield | first4 = W | title = LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 254 | issue = 1 | pages = 350–5 | year = 1990 | pmid = 2366187 }}</ref> It is orally active and has a long duration of action, producing [[antinauseant]] effects but without stimulating the rate of gastrointestinal transport.<ref>{{cite journal | last1 = Robertson | first1 = DW | last2 = Lacefield | first2 = WB | last3 = Bloomquist | first3 = W | last4 = Pfeifer | first4 = W | last5 = Simon | first5 = RL | last6 = Cohen | first6 = ML | title = Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships | journal = Journal of Medicinal Chemistry | volume = 35 | issue = 2 | pages = 310–9 | year = 1992 | pmid = 1732548 | doi=10.1021/jm00080a016}}</ref><ref>{{cite journal | last1 = Schwartz | first1 = SM | last2 = Goldberg | first2 = MJ | last3 = Gidda | first3 = JS | last4 = Cerimele | first4 = BJ | title = Effect of zatosetron on ipecac-induced emesis in dogs and healthy men | journal = Journal of clinical pharmacology | volume = 34 | issue = 3 | pages = 250–4 | year = 1994 | pmid = 7517409 | doi=10.1002/j.1552-4604.1994.tb03994.x}}</ref> It is also an effective [[anxiolytic]] in both animal studies and human trials,<ref>{{cite journal | last1 = Smith | first1 = WT | last2 = Londborg | first2 = PD | last3 = Blomgren | first3 = SL | last4 = Tollefson | first4 = GD | last5 = Sayler | first5 = ME | title = Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety | journal = Journal of Clinical Psychopharmacology | volume = 19 | issue = 2 | pages = 125–31 | year = 1999 | pmid = 10211913 | doi = 10.1097/00004714-199904000-00006 }}</ref> although with some side effects at higher doses.<ref>{{cite journal | last1 = Williams | first1 = PD | last2 = Calligaro | first2 = DO | last3 = Colbert | first3 = WE | last4 = Helton | first4 = DR | last5 = Shetler | first5 = T | last6 = Turk | first6 = JA | last7 = Jordan | first7 = WH | title = General pharmacology of a new potent 5-hydroxytryptamine antagonist | journal = Arzneimittel-Forschung | volume = 41 | issue = 3 | pages = 189–95 | year = 1991 | pmid = 1867653 }}</ref><ref>{{cite journal | last1 = Bendele | first1 = A | last2 = Means | first2 = J | last3 = Shoufler | first3 = J | last4 = Schmalz | first4 = C | last5 = Hanasono | first5 = G | last6 = Symanowski | first6 = J | last7 = Adams | first7 = E | title = Chronic toxicity of zatosetron, a 5-HT3 receptor antagonist, in rhesus monkeys | journal = Drug and chemical toxicology | volume = 18 | issue = 1 | pages = 61–82 | year = 1995 | pmid = 7768200 | doi = 10.3109/01480549509017858 }}</ref> 
== See also ==
*[[Ondansetron]]
*[[Bemesetron]]
*[[Granisetron]]
*[[Ricasetron]]
*[[Tropanserin]]
*[[Tropisetron]]

== References ==
{{Reflist|2}}


{{Anxiolytics}}
{{Antiemetics}}
{{Serotonergics}}
{{Glycinergics}}

[[Category:5-HT3 antagonists]]
[[Category:Tropanes]]
[[Category:Benzamides]]
[[Category:Benzofurans]]
[[Category:Chloroarenes]]
[[Category:Glycine receptor agonists]]
[[Category:Glycine receptor antagonists]]


{{gastrointestinal-drug-stub}}
{{nervous-system-drug-stub}}